EP3481845

C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    11.7.2017
  • EP published:
    13.9.2023
  • EP application number:
    17743136.8
  • Max expiry date:
    10.7.2037
  • Title in English:
    C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
  • Language of the patent:
    English

Timeline

Today
11.7.2017EP application
13.9.2023EP Publication

Owner

  • Name:
    Sage Therapeutics, Inc.
  • Address:
    215 First Street, Cambridge, MA 02142, US

Inventor

  • Name:
    ROBICHAUD, Albert, J.
  • Address:
    Cambridge, MA 02141, US
  • Name:
    MARTINEZ BOTELLA, Gabriel
  • Address:
    Wayland, MA 01778, US
  • Name:
    HARRISON, Boyd, L.
  • Address:
    Princeton Junction, NJ 08550, US
  • Name:
    SALITURO, Francesco, G.
  • Address:
    Marlborough, MA 01752, US
  • Name:
    GRIFFIN, Andrew
  • Address:
    L'ile Bizard, Quebec H9CZY, CA
  • Name:
    BLANCO-PILLADO, Maria, Jesus
  • Address:
    Arlington, MA 02474, US

Priority

  • Number:
    201662360813 P
  • Date:
    11.7.2016
  • Country:
    US
  • Number:
    201662360847 P
  • Date:
    11.7.2016
  • Country:
    US
  • Number:
    201662424083 P
  • Date:
    18.11.2016
  • Country:
    US

Classification

  • Categories:
    C07J 7/00, C07J 17/00, C07J 9/00, C07J 1/00, C07J 43/00, C07J 41/00, A61K 31/565, A61K 31/57, A61P 5/00, A61P 25/08, A61P 25/18, A61P 25/20, A61P 25/28, A61P 25/00, A61K 31/58, A61K 31/575, A61K 31/573

Upload documents